
Axsome Therapeutics Inc.
AXSM
NSD

Sector: Healthcare
Industry: Biotechnology
45.32
USD
-3.04
(-6.29%)
Optionable: Yes Market Cap: 1,742 M 90-day average vol: 1,376,702
Previous close: 48.36 Open: 48.36 Bid: 45.8 Ask: 45.8
52 week range
19.38 48.45
Last updated: Friday 12th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Axsome (AXSM) Posts Narrower-Than-Expected Q4 Loss
Yahoo Finance 3/2/2022
Horizon (HZNP) Q4 Earnings Beat Estimates, Revenues Rise Y/Y
Yahoo Finance 3/2/2022
Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
Yahoo Finance 3/2/2022
Why Axsome Therapeutics Stock Is Bolting Higher Today
Yahoo Finance 3/1/2022
Axsome Therapeutics, Inc.'s (AXSM) CEO Herriot Tabuteau On Q4 2021 Results - Earnings Call Transcript
Seeking Alpha 3/1/2022
Axsome stock rises 9% as company eyes potential approval/launch of drugs in FY22
Seeking Alpha 3/1/2022
This Stock Could Soar by 195%, According to Wall Street
Yahoo Finance 3/1/2022
Axsome Therapeutics GAAP EPS of -$0.90 beats by $0.08
Seeking Alpha 3/1/2022
Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Yahoo Finance 3/1/2022
Axsome Therapeutics Q4 2021 Earnings Preview
Seeking Alpha 2/28/2022
Drug/Biotech Stocks' Q4 Earnings on Mar 1: PRGO, JAZZ & More
Yahoo Finance 2/28/2022
Bristol Myers' (BMY) Breyanzi sBLA Gets FDA's Priority Review
Yahoo Finance 2/18/2022
Axsome Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
Yahoo Finance 2/15/2022
Axsome Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Yahoo Finance 2/11/2022
My Top High-Conviction Home Run Stock
Yahoo Finance 2/10/2022
Deciphera (DCPH) Q4 Loss Wider Than Expected, Revenues Beat
Yahoo Finance 2/9/2022
Catalyst's (CPRX) Stock Up on 2022 Guidance for Firdapse
Yahoo Finance 2/8/2022
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todayStand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!